CLSI M Quality Control for Commercial Microbial Identification Systems; Approved Guideline. Final document was approved through the CLSI voting process. – Publication of CLSI M Quality Control for. Commercial Microbial. Buy CLSI M50 A Ed. 1 () Quality Control For Commercial Microbial Identification Systems from SAI Global.

Author: Brasar Shagor
Country: Singapore
Language: English (Spanish)
Genre: Travel
Published (Last): 2 January 2012
Pages: 193
PDF File Size: 20.93 Mb
ePub File Size: 11.30 Mb
ISBN: 217-1-48860-393-4
Downloads: 13523
Price: Free* [*Free Regsitration Required]
Uploader: Muramar

The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.

Clinical Laboratory Improvement Advisory Committee (CLIAC)

CDC is not responsible for Section compliance accessibility on other federal or private website. CLIA ’88 2 set forth new regulations for personnel standards, specimen management, QC, PT, and quality assurance QA for all entities performing laboratory testing and mandated that testing must follow manufacturers’ recommendations. These data are critical to help clinical microbiologists understand the value in IQCP and to further motivate us to allocate resources to this time-consuming effort.

Linking to a non-federal n50-a does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.

The data showed a failure rate of less than 0. MA includes guidelines that may be followed when using an MIS of proven reliability to take a modified QC approach, rather than meeting requirements included in the Clinical Laboratory Improvement Amendments of regulations. NovemberVenue: Address correspondence to M5-0a E. Author information Copyright and License information Disclaimer.

Clinical Laboratory Improvement Act Amendments of The implementation of IQCP in clinical microbiology laboratories will most certainly be an added burden, the benefits of which are currently unknown.

Standards Subscriptions from ANSI provides a money-saving, multi-user solution for accessing standards. Spring Meeting Summary Report Cdc-pdf. US Statutes at Large The power in these numbers is obvious, and there is ample evidence to categorize media as being exempt or nonexempt.


These data showed that the failure rate due to the MIS itself was less than 0. For decades, the QC recommendations in the CLSI documents have effectively identified problems in clinical microbiology testing systems for which they are designed.

Individualized Quality Control Plan (IQCP): Is It Value-Added for Clinical Microbiology?

Your Alert Profile lists the documents that will be monitored. However, it is unlikely that the development of an IQCP for these tests will discover n50-a additional QC will lead to improved patient care. Performance standards for antimicrobial susceptibility testing; 25th informational supplement.

The streamlined C,si approach was developed following an evaluation of data provided by the American Society for Microbiology for a survey conducted to determine the QC failure rates of commercial MISs. Published online Nov Clinical and Laboratory Standards Institute.

Results of the survey of the quality assurance for commercially prepared microbiology media.

CLSI document EP23 also describes good laboratory practice for developing and maintaining a quality control program for medical laboratory testing cllsi recognized risk management principles. Likewise, for commercial microbial identification systems MIS that use two or more substrates, CLIA ’88 requires QC testing with positive and negative reactivity controls for each substrate with each batch, lot number, and shipment of reagents.

Individualized Quality Control Plan (IQCP): Is It Value-Added for Clinical Microbiology?

Statutes at Large 81 US Statutes at Large 81 You clzi delete a document from your Alert Profile at any time. This standard is not included in any packages. We also understand that there clxi common errors in microbiology that need to be managed; however, it is difficult to see how the implementation of IQCP and the elimination of both EQC and the use of recommendations in CLSI standards and guidelines will have a positive effect for our patients.


The QC recommendations in the CLSI standards are supported by data demonstrating that following CLIA default QC daily testing of QC strains will not improve the quality of patient results for laboratories that have documented satisfactory performance with a specified amount of daily QC testing.

You can download and open this file to your own computer but DRM prevents opening this file on another computer, including a networked server.

Clinical Laboratory Improvement Advisory Committee (CLIAC) | DLS |CDC

Several decades ago, it was recognized that testing of QC strains by the user for commercially m5-a media demonstrated few QC failures and imposed a substantial financial burden on microbiology laboratories. J Clin Microbiol On 2 SeptemberASM’s Committee on Laboratory Practices wrote a letter to Andrew Slavitt, Acting Administrator for CMS, stating that we as clinical scientists rely on published literature, statistically derived data, and evidence-based medicine to guide our practice http: College of American Pathologists.

Statistician’s summary for alternative QC frequency testing proposal.

A discussion of the statistical considerations that support the CLSI recommendations for frequency of QC testing is available Laboratory quality csi based on risk management; approved guideline. Nearly laboratories provided data for nearly 10, lots of MIS. We have no amendments or corrections for this standard.

Author: admin